RWE Aktiengesellschaft (WSE:RWE)

Verve Therapeutics Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	113,047	91,145	133,037	131,605	110,737	106,763
Market Cap Growth	1.24%	-31.49%	1.09%	18.84%	3.72%	49.43%
Enterprise Value	172,119	139,167	155,695	229,121	141,287	95,833
PE Ratio	6.82	4.15	20.21	10.35	33.49	22.23
PS Ratio	1.25	0.88	1.07	0.73	0.98	1.70
PB Ratio	0.76	0.63	0.91	0.96	1.42	1.32
P/FCF Ratio	-	-	-	-	6.74	28.60
P/OCF Ratio	4.03	3.22	7.25	11.69	3.32	5.60
EV/Sales Ratio	1.86	1.34	1.26	1.27	1.25	1.52
EV/EBITDA Ratio	5.43	3.84	4.91	-	10.65	5.00
EV/EBIT Ratio	7.18	4.79	6.43	-	18.83	7.38
EV/FCF Ratio	-10.78	-	-	-	8.59	25.67
Debt / Equity Ratio	0.56	0.56	0.51	0.72	1.05	0.29
Debt / EBITDA Ratio	2.87	2.15	2.27	-	5.82	1.21
Debt / FCF Ratio	-	-	-	-	4.96	6.36
Quick Ratio	0.60	0.72	0.70	0.39	0.22	0.76
Current Ratio	1.21	1.27	1.53	1.21	1.07	1.65
Asset Turnover	0.22	0.24	0.23	0.27	0.24	0.22
Return on Equity (ROE)	11.80%	15.73%	5.29%	12.93%	4.79%	5.05%
Return on Assets (ROA)	3.25%	4.14%	2.84%	-0.88%	1.00%	2.83%
Return on Capital (ROIC)	6.04%	8.25%	6.90%	-2.91%	3.55%	7.73%
Return on Capital Employed (ROCE)	7.30%	9.60%	7.60%	-	3.60%	6.30%
Earnings Yield	14.65%	24.11%	4.95%	9.66%	2.99%	4.50%
Earnings Yield	14.65%	24.11%	4.95%	9.66%	2.99%	4.50%
FCF Yield	-14.12%	-12.94%	-3.02%	-3.19%	14.85%	3.50%
Dividend Yield	3.12%	4.04%	3.08%	-	-	-
Payout Ratio	17.82%	14.49%	44.16%	22.41%	79.75%	49.67%
Buyback Yield / Dilution	0.24%	0.04%	-7.61%	-2.22%	-6.11%	-3.67%
Total Shareholder Return	3.36%	4.08%	-4.53%	-2.22%	-6.11%	-3.67%

Source: S&P Global Market Intelligence. Utility template. Financial Sources.